Clinical Trial

Efficacy of OsteoBor in Postmenopausal Osteoporosis

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 5, 2025 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the impact of boron supplementation (OsteoBor) on bone health in postmenopausal women. The trial is a phase 2, randomised, double-blind, placebo-controlled study lasting one year
Trial Details
NCT Number NCT06809816
Lead Sponsor Tabriz University of Medical Sciences
Conditions Osteoporosis, Postmenopausal
Enrollment 30 participants
Start Date 2025-03-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-05